NLRP3 and neoplasm: In the study, it was shown that oral administration of e-As4S4 significantly increased arsenic accumulation and eliminated ROS from tumor tissues and reduced angiogenesis, inflammasome in the tumor microenvironment by inhibiting the expression of inducible factor-1α (HIF-1α), thereby inhibiting NLRP3 expression.